Compositions and methods for providing effects
AssigneeG Tech Bio LLC
InventorSerhat Gumrukcu
Life of this patent
Estimating the term…
Abstract
The disclosure relates to compositions and methods for providing chemoprotective effects to target cells.
Claims18
1-5. (canceled)
A method of treating a patient with cancer or HIV, the method comprising administering to the patient a pharmaceutical composition comprising a cell expressing heterologous glutamate-cysteine ligase (GCL) modifier subunit GCLM, GCLC (GCL catalytic subunit), GCL (as a dimer or a full enzyme), or any other polypeptide in the GSH synthesis pathway that provide the equivalent function with a non-myeloablative or a myeloablative dose of a chemotherapeutic.
9-14. (canceled)
16-19. (canceled)
22-73. (canceled)
An isolated stem cell or an immune cell comprising heterologous glutamate-cysteine ligase (GCL) modifier subunit GCLM, GCLC (GCL catalytic subunit), GCL (as a dimer or a full enzyme), or any other polypeptide in the GSH synthesis pathway that provide the equivalent function and at least one additional heterologously expressed molecule of interest.
76-78. (canceled)
The cell of claim 24, wherein the cell is a T cell that further comprises a chimeric antigen receptor (CAR).
80-83. (canceled)
86-90. (canceled)
Dependencies are inferred from the claim text.